weight loss at target dose (trial data) ~6% CV risk reduction labelled Yes (T2D + CVD) Format Prefilled FlexTouch pen India price (May 2026) 5,6609,100/month DCGI-approved Yes (pre-2026) Generic competition in India n/a (innovator) Wegovy Novo Nordisk semaglutide Active molecule Semaglutide Receptor activity GLP-1 Primary indication Chronic weight management Max maintenance dose 2.4 mg weekly Avg
Inconclusive No Result Your genetic data for rs1805007, a MC1R gene variant, was not successfully called by the laboratory
Press release - Intarcia announces successful cardiovascular safety results in phase 3 FREEDOM-CVO Trial for ITCA 650, an investigational therapy for type 2 diabetes
A Under Labz se esfora para entregar produtos de qualidade a preos acessveis
Never discontinue GLP-1 medication without medical guidance, as abrupt cessation may worsen glycaemic control or cause weight regain
If youre interested in Mounjaro and how it can help with weight loss, schedule a consultation with our team to create a treatment plan tailored to your needs